Development and Validation of a Spectrophotometric Method for the Estimation of Bictegravir using Chromogenic agents in Bulk and Pharmaceutical Dosage forms

A simple, precise, and accurate UV spectrophotometric method was developed and validated for the estimation of Bictegravir in tablet dosage forms. The method utilized methanol as a solvent, with λmax values determined to be 330 nm and 760 nm for reactions with the chromogenic reagents 2,4-dinitrophenylhydrazine (2,4-DNPH) and potassium ferrocyanide, respectively. Linearity was established within the concentration ranges of 10–25 µg/ml for 2,4-DNPH and 1–5 µg/ml for potassium ferrocyanide, both exhibiting R² values of 0.999.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-12-11
DOI
https://doi.org/10.5281/zenodo.14384597
Primary Topic
HIV/AIDS drug development and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development and Validation of a Spectrophotometric Method for the Estimation of Bictegravir using Chromogenic agents in Bulk and Pharmaceutical Dosage forms

Zenodo (CERN European Organization for Nuclear Research)
HIV/AIDS drug development and treatment
article

Development and Validation of a Spectrophotometric Method for the Estimation of Bictegravir using Chromogenic agents in Bulk and Pharmaceutical Dosage forms

article en

Abstract

A simple, precise, and accurate UV spectrophotometric method was developed and validated for the estimation of Bictegravir in tablet dosage forms. The method utilized methanol as a solvent, with λmax values determined to be 330 nm and 760 nm for reactions with the chromogenic reagents 2,4-dinitrophenylhydrazine (2,4-DNPH) and potassium ferrocyanide, respectively. Linearity was established within the concentration ranges of 10–25 µg/ml for 2,4-DNPH and 1–5 µg/ml for potassium ferrocyanide, both exhibiting R² values of 0.999.

Zenodo (CERN European Organization for Nuclear Research)
Industry, innovation and infrastructure
Openalex Percentile: Top 65%
HIV/AIDS drug development and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Development and Validation of a Spectrophotometric Method for the Estimation of Bictegravir using Chromogenic agents in Bulk and Pharmaceutical Dosage forms · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS